Systemic Vasculitis: Clinical Trials

2 trials for Systemic Vasculitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Unknown 2

Follow Systemic Vasculitis: new trials by email Literature Review of Systemic Vasculitis trials Research Report on Systemic Vasculitis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases
CD19-CAR-DNT cells - Systemic Lupus Erythematosus, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Phase 1UnknownRenJi Hospital482023-10-302024-03-18
Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease
CD19 targeted CAR-T cells - SLE (Systemic Lupus), Sjogren's Syndrome
Phase 1UnknownChongqing Precision Biotech Co., Ltd242023-08-312023-09-28

Narrower conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2)  ·  Lupus Erythematosus, Systemic (2)  ·  Scleroderma, Systemic (2)  ·  Dermatomyositis (1)  ·  Myositis (1)  ·  Sjogren's Syndrome (1)

Broader conditions

Autoimmune Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Connective Tissue Diseases (2)  ·  Immune System Diseases (2)  ·  Muscular Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Nervous System Diseases (2)  ·  Neuromuscular Diseases (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Vascular (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Vascular Diseases (2)  ·  Vasculitis (2)  ·  Arthritis (1)

Interventions

Cyclophosphamide (1)  ·  fludarabine (1)

Sponsors

Chongqing Precision Biotech Co., Ltd (1)  ·  RenJi Hospital (1)

Countries

China (2)

Top investigators

Liyun Zhang, M.D (1)